Cargando…

Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis

BACKGROUND: Longitudinal studies of health-related quality of life (HRQoL) in multiple sclerosis (MS) are limited. Most have examined average changes within the population, rather than dynamic changes within individuals. OBJECTIVE: To assess the between- and within-individual association between dep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrie, Ruth Ann, Bernstein, Charles N, Dolovich, Casandra, Bolton, James M, Graff, Lesley A, Hitchon, Carol A, Lix, Lisa M, Marriott, James J, Fisk, John D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580669/ https://www.ncbi.nlm.nih.gov/pubmed/37537962 http://dx.doi.org/10.1177/13524585231190771

Ejemplares similares

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis
por: Jain, Dhruv, et al.
Publicado: (2023)

Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases
por: Enns, Murray W., et al.
Publicado: (2018)

Effect of mood and anxiety disorders on health care utilization in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study
por: Almweisheer, Shaza, et al.
Publicado: (2023)

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis
por: Hitchon, Carol A., et al.
Publicado: (2020)

Prescription opioid use in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2017)

Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis
por: Fiest, Kirsten M., et al.
Publicado: (2017)

Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease
por: Kowalec, Kaarina, et al.
Publicado: (2022)

Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population‐Based Study
por: Hitchon, Carol A., et al.
Publicado: (2020)

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
por: Fiest, Kirsten M., et al.
Publicado: (2016)

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed
por: Carter, Sean L., et al.
Publicado: (2023)

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis
por: Kowalec, Kaarina, et al.
Publicado: (2021)

Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease
por: Patel, Ronak, et al.
Publicado: (2023)

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases
por: Blaney, C., et al.
Publicado: (2020)

The Seasonal Fluctuation of Fatigue in Multiple Sclerosis
por: Grothe, Matthias, et al.
Publicado: (2022)

The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol: Study rationale, MRI acquisition, and minimal image processing pipelines
por: Uddin, Md Nasir, et al.
Publicado: (2022)

Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease
por: Carney, Heather, et al.
Publicado: (2020)

Development of an indicator of smoking status for people with multiple sclerosis in administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

The Association Between Increased Maladaptive Health Behaviours and Elevated Mental Health Symptoms Among Persons with IBD During the COVID-19 Pandemic
por: Dolovich, Casandra L, et al.
Publicado: (2023)

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Jain, Avni, et al.
Publicado: (2019)

Effect of comorbidity on mortality in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease
por: Marrie, R. A., et al.
Publicado: (2017)

Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study
por: McKay, Kyla A., et al.
Publicado: (2015)

Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study
por: Bernstein, Charles N., et al.
Publicado: (2015)

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study
por: Hitchon, Carol A, et al.
Publicado: (2023)

Severity and worsening of fatigue among individuals with multiple sclerosis
por: Salter, Amber, et al.
Publicado: (2023)

Incidence and prevalence of multiple sclerosis in Europe: a systematic review
por: Kingwell, Elaine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k1vgvdp45eeil4ogv607o9civp